Hyperdopaminergic modulation of inhibitory transmission is dependent on GSK-3β signaling-mediated trafficking of GABAA receptors

Journal of Neurochemistry

Volumn 122, Issue 2, 2012, Pages 308-320

  Li, Yan Chun ^a   Wang, Min Juan ^b   Gao, Wen Jun ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

dopamine; GSK 3; inhibitory synaptic transmission; neocortex; receptor trafficking

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BETA2; 4 AMINOBUTYRIC ACID A RECEPTOR BETA3; BREFELDIN A; DOPAMINE; DOPAMINE UPTAKE INHIBITOR; DYNAMIN; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNALIZATION; NERVE CELL; NEWBORN; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION;

ANIMALS; CELLS, CULTURED; CROSS-LINKING REAGENTS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DYNAMINS; ELECTROPHYSIOLOGICAL PHENOMENA; EXCITATORY POSTSYNAPTIC POTENTIALS; GLYCOGEN SYNTHASE KINASE 3; GUANINE NUCLEOTIDE EXCHANGE FACTORS; INOSITOL 1,4,5-TRISPHOSPHATE; PATCH-CLAMP TECHNIQUES; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, GABA-A; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 84863334186     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07790.x     Document Type: Article

References (71)

1. Asaumi Y., Hasuo H., and, Akasu T., (2006) Dopamine presynaptically depresses fast inhibitory synaptic transmission via D4 receptor-protein kinase A pathway in the rat dorsolateral septal nucleus. J. Neurophysiol. 96, 591-601. (Pubitemid 44155199)
2. Baufreton J., and, Bevan M. D., (2008) D2-like dopamine receptor-mediated modulation of activity-dependent plasticity at GABAergic synapses in the subthalamic nucleus. J. Physiol. 586, 2121-2142. (Pubitemid 351524567)
3. Beaulieu J. M., Sotnikova T. D., Yao W. D., Kockeritz L., Woodgett J. R., Gainetdinov R. R., and, Caron M. G., (2004) Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci USA 101, 5099-5104. (Pubitemid 38469209)
4. Beaulieu J. M., Sotnikova T. D., Marion S., Lefkowitz R. J., Gainetdinov R. R., and, Caron M. G., (2005) An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122, 261-273. (Pubitemid 41032989)
5. Beaulieu J. M., Gainetdinov R. R., and, Caron M. G., (2007) The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol. Sci. 28, 166-172. (Pubitemid 46483722)
6. Beaulieu J. M., Gainetdinov R. R., and, Caron M. G., (2009) Akt/GSK3 signaling in the action of psychotropic drugs. Annu. Rev. Pharmacol. Toxicol. 49, 327-347.
7. Bersudsky Y., Shaldubina A., Kozlovsky N., Woodgett J. R., Agam G., and, Belmaker R. H., (2008) Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results. Behav. Pharmacol. 19, 217-224. (Pubitemid 351670402)
8. Charych E. I., Yu W., Miralles C. P., Serwanski D. R., Li X., Rubio M., and, De Blas A. L., (2004) The brefeldin A-inhibited GDP/GTP exchange factor 2, a protein involved in vesicular trafficking, interacts with the beta subunits of the GABA receptors. J. Neurochem. 90, 173-189. (Pubitemid 38879172)
9. Chen P., Gu Z., Liu W., and, Yan Z., (2007) Glycogen synthase kinase 3 regulates N-methyl-D-aspartate receptor channel trafficking and function in cortical neurons. Mol. Pharmacol. 72, 40-51. (Pubitemid 46998523)
10. Cross D. A., Alessi D. R., Cohen P., Andjelkovich M., and, Hemmings B. A., (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789. (Pubitemid 26004411)
11. Cuitino L., Godoy J. A., Farias G. G., Couve A., Bonansco C., Fuenzalida M., and, Inestrosa N. C., (2010) Wnt-5a modulates recycling of functional GABAA receptors on hippocampal neurons. J. Neurosci. 30, 8411-8420.
12. Davis K. L., Kahn R. S., Ko G., and, Davidson M., (1991) Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiatry 148, 1474-1486.
13. Delgado A., Sierra A., Querejeta E., Valdiosera R. F., and, Aceves J., (2000) Inhibitory control of the GABAergic transmission in the rat neostriatum by D2 dopamine receptors. Neuroscience 95, 1043-1048.
14. Diaz M. R., Chappell A. M., Christian D. T., Anderson N. J., and, McCool B. A., (2011) Dopamine D3-like receptors modulate anxiety-like behavior and regulate GABAergic transmission in the rat lateral/basolateral amygdala. Neuropsychopharmacology 36, 1090-1103.
15. Egan M. F., and, Weinberger D. R., (1997) Neurobiology of schizophrenia. Curr. Opin. Neurobiol. 7, 701-707. (Pubitemid 27500832)
16. Emamian E. S., Hall D., Birnbaum M. J., Karayiorgou M., and, Gogos J. A., (2004) Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 36, 131-137. (Pubitemid 38174370)
17. Floresco S. B., and, Tse M. T., (2007) Dopaminergic regulation of inhibitory and excitatory transmission in the basolateral amygdala-prefrontal cortical pathway. J. Neurosci. 27, 2045-2057.
18. Flores-Hernandez J., Hernandez S., Snyder G. L., Yan Z., Fienberg A. A., Moss S. J., Greengard P., and, Surmeier D. J., (2000) D1 dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade. J. Neurophysiol. 83, 2996-3004. (Pubitemid 30321488)
19. Freyberg Z., Ferrando S. J., and, Javitch J. A., (2010) Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. Am. J. Psychiatry 167, 388-396.
20. Fujii M., Kanematsu T., Ishibashi H., Fukami K., Takenawa T., Nakayama K. I., Moss S. J., Nabekura J., and, Hirata M., (2010) Phospholipase C-related but catalytically inactive protein is required for insulin-induced cell surface expression of gamma-aminobutyric acid type A receptors. J. Biol. Chem. 285, 4837-4846.
21. Gao W. J., Wang Y., and, Goldman-Rakic P. S., (2003) Dopamine modulation of perisomatic and peridendritic inhibition in prefrontal cortex. J. Neurosci. 23, 1622-1630. (Pubitemid 36314717)
22. George S. R., and, O'Dowd B. F., (2007) A novel dopamine receptor signaling unit in brain: heterooligomers of D1 and D2 dopamine receptors. ScientificWorldJournal 7, 58-63.
23. Goldman-Rakic P. S., (1995) Cellular basis of working memory. Neuron 14, 477-485.
24. Goldman-Rakic P. S., Castner S. A., Svensson T. H., Siever L. J., and, Williams G. V., (2004) Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology 174, 3-16. (Pubitemid 38925085)
25. Gonzalez-Islas C., and, Hablitz J. J., (2001) Dopamine inhibition of evoked IPSCs in rat prefrontal cortex. J. Neurophysiol. 86, 2911-2918. (Pubitemid 33139058)
26. Greengard P., (2001) The neurobiology of slow synaptic transmission. Science 294, 1024-1030. (Pubitemid 33041850)
27. Greengard P., Allen P. B., and, Nairn A. C., (1999) Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23, 435-447. (Pubitemid 29359916)
28. Harrison P. J., and, Weinberger D. R., (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10, 40-68. (Pubitemid 40139588)
29. Herring D., Huang R., Singh M., Robinson L. C., Dillon G. H., and, Leidenheimer N. J., (2003) Constitutive GABAA receptor endocytosis is dynamin-mediated and dependent on a dileucine AP2 adaptin-binding motif within the beta 2 subunit of the receptor. J. Biol. Chem. 278, 24046-24052. (Pubitemid 36830237)
30. Hjelmstad G. O., (2004) Dopamine excites nucleus accumbens neurons through the differential modulation of glutamate and GABA release. J. Neurosci. 24, 8621-8628. (Pubitemid 39313784)
31. Howes O. D., and, Kapur S., (2009) The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophr. Bull. 35, 549-562.
32. Janssen M. J., Ade K. K., Fu Z., and, Vicini S., (2009) Dopamine modulation of GABA tonic conductance in striatal output neurons. J. Neurosci. 29, 5116-5126.
33. Kanematsu T., Yasunaga A., Mizoguchi Y., et al. (2006) Modulation of GABA(A) receptor phosphorylation and membrane trafficking by phospholipase C-related inactive protein/protein phosphatase 1 and 2A signaling complex underlying brain-derived neurotrophic factor-dependent regulation of GABAergic inhibition. J. Biol. Chem. 281, 22180-22189. (Pubitemid 44181922)
34. Kittler J. T., and, Moss S. J., (2003) Modulation of GABAA receptor activity by phosphorylation and receptor trafficking: implications for the efficacy of synaptic inhibition. Curr. Opin. Neurobiol. 13, 341-347. (Pubitemid 36792247)
35. Kittler J. T., Delmas P., Jovanovic J. N., Brown D. A., Smart T. G., and, Moss S. J., (2000) Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons. J. Neurosci. 20, 7972-7977.
36. Kittler J. T., Chen G., Honing S., et al. (2005) Phospho-dependent binding of the clathrin AP2 adaptor complex to GABAA receptors regulates the efficacy of inhibitory synaptic transmission. Proc. Natl Acad. Sci. USA 102, 14871-14876. (Pubitemid 41457148)
37. Koros E., and, Dorner-Ciossek C., (2007) The role of glycogen synthase kinase-3beta in schizophrenia. Drug News Perspect 20, 437-445. (Pubitemid 350232812)
38. Kozlovsky N., Belmaker R. H., and, Agam G., (2002) GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Eur. Neuropsychopharmacol. 12, 13-25. (Pubitemid 34098826)
39. Kroener S., and, Lavin A., (2010) Altered dopamine modulation of inhibition in the prefrontal cortex of cocaine-sensitized rats. Neuropsychopharmacology 35, 2292-2304.
40. Kroner S., Krimer L. S., Lewis D. A., and, Barrionuevo G., (2007) Dopamine increases inhibition in the monkey dorsolateral prefrontal cortex through cell type-specific modulation of interneurons. Cereb. Cortex 17, 1020-1032. (Pubitemid 46598843)
41. Law-Tho D., Hirsch J. C., and, Crepel F., (1994) Dopamine modulation of synaptic transmission in rat prefrontal cortex: an in vitro electrophysiological study. Neurosci. Res. 21, 151-160.
42. Lewis D. A., and, Gonzalez-Burgos G., (2006) Pathophysiologically based treatment interventions in schizophrenia. Nat. Med. 12, 1016-1022. (Pubitemid 44353381)
43. Li Y. C., and, Gao W. J., (2011) GSK-3beta activity and hyperdopamine-dependent behaviors. Neurosci. Biobehav. Rev. 35, 645-654.
44. Li Y. C., Xi D., Roman J., Huang Y. Q., and, Gao W. J., (2009) Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex. J. Neurosci. 29, 15551-15563.
45. Li Y. C., Kellendonk C., Simpson E. H., Kandel E. R., and, Gao W. J., (2011) D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex. Proc. Natl Acad. Sci. USA 108, 12107-12112.
46. Lovestone S., Killick R., Di Forti M., and, Murray R., (2007) Schizophrenia as a GSK-3 dysregulation disorder. Trends Neurosci. 30, 142-149. (Pubitemid 46482684)
47. Lute B. J., Khoshbouei H., Saunders C., Sen N., Lin R. Z., Javitch J. A., and, Galli A., (2008) PI3K signaling supports amphetamine-induced dopamine efflux. Biochem. Biophys. Res. Commun. 372, 656-661.
48. Michaeli A., and, Yaka R., (2010) Dopamine inhibits GABA(A) currents in ventral tegmental area dopamine neurons via activation of presynaptic G-protein coupled inwardly-rectifying potassium channels. Neuroscience 165, 1159-1169.
49. Missale C., Fiorentini C., Busi C., Collo G., and, Spano P. F., (2006) The NMDA/D1 receptor complex as a new target in drug development. Curr. Top. Med. Chem. 6, 801-808.
50. Momiyama T., and, Sim J. A., (1996) Modulation of inhibitory transmission by dopamine in rat basal forebrain nuclei: activation of presynaptic D1-like dopaminergic receptors. J. Neurosci. 16, 7505-7512. (Pubitemid 26389689)
51. Naylor J. C., Li Q., Kang-Park M. H., Wilson W. A., Kuhn C., and, Moore S. D., (2010) Dopamine attenuates evoked inhibitory synaptic currents in central amygdala neurons. Eur. J. Neurosci. 32, 1836-1842.
52. Neve K. A., Seamans J. K., and, Trantham-Davidson H., (2004) Dopamine receptor signaling. J. Recept. Signal Transduct. Res. 24, 165-205. (Pubitemid 39332216)
53. Pan B., Hillard C. J., and, Liu Q. S., (2008) D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling. J. Neurosci. 28, 14018-14030.
54. Peineau S., Taghibiglou C., Bradley C., et al. (2007) LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 53, 703-717. (Pubitemid 46283369)
55. Peineau S., Bradley C., Taghibiglou C., Doherty A., Bortolotto Z. A., Wang Y. T., and, Collingridge G. L., (2008) The role of GSK-3 in synaptic plasticity. Br. J. Pharmacol. 153, S428-437. (Pubitemid 351341021)
56. Peineau S., Nicolas C. S., Bortolotto Z. A., Bhat R. V., Ryves W. J., Harwood A. J., Dournaud P., Fitzjohn S. M., and, Collingridge G. L., (2009) A systematic investigation of the protein kinases involved in NMDA receptor-dependent LTD: evidence for a role of GSK-3 but not other serine/threonine kinases. Mol Brain 2, 22.
57. Penit-Soria J., Audinat E., and, Crepel F., (1987) Excitation of rat prefrontal cortical neurons by dopamine: an in vitro electrophysiological study. Brain Res. 425, 263-274. (Pubitemid 18025714)
58. Romo-Parra H., Aceves J., and, Gutierrez R., (2005) Tonic modulation of inhibition by dopamine D4 receptors in the rat hippocampus. Hippocampus 15, 254-259. (Pubitemid 40458424)
59. Seamans J. K., and, Yang C. R., (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog. Neurobiol. 74, 1-58.
60. Seamans J. K., Gorelova N., Durstewitz D., and, Yang C. R., (2001) Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J. Neurosci. 21, 3628-3638. (Pubitemid 32422827)
61. Simpson E. H., Kellendonk C., and, Kandel E., (2010) A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron 65, 585-596.
62. Swant J., Stramiello M., and, Wagner J. J., (2008) Postsynaptic dopamine D3 receptor modulation of evoked IPSCs via GABA(A) receptor endocytosis in rat hippocampus. Hippocampus 18, 492-502. (Pubitemid 351671408)
63. Tehrani M. H., and, Barnes E. M. Jr, (1993) Identification of GABAA/benzodiazepine receptors on clathrin-coated vesicles from rat brain. J. Neurochem. 60, 1755-1761. (Pubitemid 23127580)
64. Trantham-Davidson H., Neely L. C., Lavin A., and, Seamans J. K., (2004) Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex. J. Neurosci. 24, 10652-10659. (Pubitemid 39557638)
65. Tyagarajan S. K., Ghosh H., Yévenes G. E., et al. (2011) Regulation of GABAergic synapse formation and plasticity by GSK3β-dependent phosphorylation of gephyrin. Proc. Nat. Acad. Sci. 108, 379-384.
66. Vetiska S. M., Ahmadian G., Ju W., Liu L., Wymann M. P., and, Wang Y. T., (2007) GABAA receptor-associated phosphoinositide 3-kinase is required for insulin-induced recruitment of postsynaptic GABAA receptors. Neuropharmacology 52, 146-155. (Pubitemid 46039779)
67. Wang X., Zhong P., and, Yan Z., (2002) Dopamine D4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex. J. Neurosci. 22, 9185-9193. (Pubitemid 35356161)
68. Wang Q., Liu L., Pei L., Ju W., Ahmadian G., Lu J., Wang Y., Liu F., and, Wang Y. T., (2003) Control of synaptic strength, a novel function of Akt. Neuron 38, 915-928. (Pubitemid 36782383)
69. Wei J., Liu W., and, Yan Z., (2010) Regulation of AMPA receptor trafficking and function by glycogen synthase kinase 3. J. Biol. Chem. 285, 26369-26376.
70. Zhou F. M., and, Hablitz J. J., (1999) Dopamine modulation of membrane and synaptic properties of interneurons in rat cerebral cortex. J. Neurophysiol. 81, 967-976. (Pubitemid 29272416)
71. Zhu L. Q., Wang S. H., Liu D., Yin Y. Y., Tian Q., Wang X. C., Wang Q., Chen J. G., and, Wang J. Z., (2007) Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments. J. Neurosci. 27, 12211-12220. (Pubitemid 350085482)